Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: Impact on the search for vaginal microbicides

Journal of Medical Virology

Volumn 61, Issue 1, 2000, Pages 107-110

  Neyts, Johan ^a   Kristmundsdottir T ^b   De Clercq, Erik ^a   Thormar, Halldor ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Chlamydia; HIV; HSV; Neisseria; Sexual transmitted diseases; Vaginal microbicides; Virucides

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; DECANOIC ACID DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; FEMALE; HERPES SIMPLEX VIRUS 2; HYDROGEL; INFECTION PREVENTION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTIVIRAL AGENTS; FEMALE; GLYCERIDES; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HYDROGELS; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED HRS; VAGINA; VAGINITIS;

ANIMALIA; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 2; NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 0342313696     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200005)61:1<107::AID-JMV17>3.0.CO;2-W     Document Type: Article

References (18)

1. Balzarini J, Naesens L, Verbeken E, et al. 1998. Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent. AIDS 12:1129-1138.
2. Bergsson G, Arnfinnsson J, Karlsson SM, Steingríson O, Thormar O. 1998. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother 42:2290-2294.
3. Bergsson G, Steingríson O, Thormar H. 1999. In vitro susceptibility of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrob Agents Chemother 43:2790-2792.
4. Cook RL Rosenberg MJ. 1998. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis. Sex Transm Dis 25:144-150.
5. Hira SK, Feldblum PJ, Kamanga J, Mukelabai G, Weir SS, Thomas JC. 1997. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS 8:243-250.
6. Kreiss J, Ngugi E, Holmes E, et al. 1992. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 268:477-482.
7. Kristmundsdóttir T, Arnadóttir SG, Bergsson G, Thormar H. 1999. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient. J Pharm Sci 88:1011-1015.
8. Malkovsky M, Newell A, Dalgleish A. 1988. Inactivation of HIV by nonoxynol-9. Lancet i:645.
9. Neyts J, De Clercq E. 1995. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. J Acquire Immune Defic Syndr Hum Retrovirol 10:8-12.
10. Roddy RE, Schulz KF, Cates W Jr. 1998b. Microbicides, meta-analysis, and the N-9 question: where's the research? Sex Transm Dis 25:151-153.
11. Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL. 1998a. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 339:504-510.
12. Stafford M, Cain D, Rosenstein I, et al. 1997. A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel. J Acquir Immun Defic Syndr Hum Retrovirol 14:213-218.
13. Stafford MK, Ward H, Flanagan A, et al. 1998. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immun Defic Syndr Hum Retrovirol 17:327-331.
14. Thormar H, Bergsson G, Gunnarsson E, et al. 1999. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex Transm Infect 75:181-185.
15. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. 1987. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31:27-31.
16. Van Damme L, Niruthisard S, Atisook R, et al. 1998. Safety evaluation of nonoxynol-9 in women at low risk of HIV infection. AIDS 12:433-437.
17. Visness CM, Ulin P, Pfannenschmidt S, Zeking L. 1998. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection. Int J STD AIDS 9:695-699.
18. Zekeng L, Feldblum P, Oliver RM, Kaptue L. 1993. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 7:725-731.